Spine
Introduction
Spinal gout was fi rst described by Kersley et al. 1 in 1950, and in 1953 Koskoff et al. 2 reported the fi rst case of myelopathy due to gout. Since then, several cases of spinal gout have been reported, with manifestations ranging from an asymptomatic clinical picture to serious complications, such as paraplegia and quadriparesis (see Table 1 with case reports cited). This study reviews the literature related to clinical manifestations, diagnosis and treatment of spinal involvement due to gout.
Methods
A bibliographical search for the terms spine, gout, tophus, and myelopathy was carried out on PubMed and Medline, and a selection of articles describing spinal gout, including case reports, letters to the editor, radiological fi ndings, systematic reviews and observational trials was made. Cross-referencing cases among these reports, that were absent in initial search, were also included in the current review. The fi nal number of articles was 94, and a total of 113 subjects were included in these reports. Our search also found two larger studies regarding axial gout and radiological image, one with a retrospective design and the other one being a prospective study. No previous reviews regarding this subject included these two studies, and neither had such a comprehensive search for case reports.
Results

Clinical manifestations
The mean age of the 113 patients was 60.3 ± 14.4 years ranging from 17 to 85 years, 3, 4 and 70.8% were male. A previous history of gout was observed in 62 patients (65.9% of the reports that mentioned this information), and 31 of them were tophaceous. There was no reference to a history of hyperuricemia and/or gout in 19 (16.8%) patients.
Serum uric acid was measured at the diagnosis in 69 patients and 48 (69.6%) presented with high levels. Renal insuffi ciency was reported in 25 cases (22.1%) and a previous history of renal transplant in another 7 (6.2%). [4] [5] [6] Alcohol use and diuretic regimen was reported only in 7 (6.2%) and 12 (10.6%) cases, respectively.
Spinal involvement was the initial manifestation of gout in 28 patients (24.8%). All spinal segments were affected: the lumbar spine in 66 of the 113 patients (58.4%); the cervical spine in 28 (24.8%); and the thoracic spine in 24 (21.2%). The involvement of S1 was observed in 15 cases (13.3%), associated with lumbar spine lesions in 13 (86.7%) of them. Two patients (1.8%) had both cervical and thoracic lesions, 7, 8 and another four (3.5%) had simultaneous thoracic and lumbar involvement. 5, [9] [10] [11] Gout may affect any spinal structure, such as intervertebral discs, facet joints, laminae, vertebral bodies, pedicles, ligamentum fl avum, fi lum terminale and the soft tissues adjacent to the spinal column. 12 Neurological symptoms were observed in 88 patients (77.9%), and there was an association with cervical, thoracic or lumbar pain in 80 (90.9%) of these cases. Pain with no neurologic symptom was reported in 23 patients (20.4%), 3 (2.7%) in the cervical spine, 1 (0.9%) in the thoracic spine, 20 (17.7%) in the lumbar spine (one case with both cervical and lumbar pain, and one report with both lumbar and thoracic involvement) and 1 (0.9%) with pain over the sacrum. Two (1.8%) patients were asymptomatic and were only diagnosed on autopsy (Table 2) . 13, 14 Radiculopathy (motor dysfunction or dysesthesia along the course of a specifi c nerve caused by compression of its root) was the most frequent neurological symptom, occurring in 39 patients (34.5%), followed by claudication in 23 (20.4%), crural paraparesis in 14 (12.4%), quadriparesis in 8 (7.1%), and paraplegia in 5 (4.4%). Atlanto-axial subluxation with the presence of tophus was observed in two cases of cervical pain leading to quadriparesis, 15, 16 and in one case of multiple cranial nerves palsy. 17 Neurologic symptoms without pain were related in 8 patients (7.1%).
Bladder and/or bowel dysfunction was observed in 10 subjects, all of them presenting with other neurological manifestations, and 5 with back pain. Thirty-four (38.6%) of the 88 cases with neurological impairment exhibited acute onset of symptoms (four weeks or less prior to diagnosis).
Fever higher than 38 °C was reported in 15 patients (10.6%), all of them with elevated erythrocyte sedimentation rate (ESR) and C reactive protein; therefore, exclusion of an infectious process was mandatory. Additionally, further 12 cases without fever had elevated ESR.
Imaging studies
As observed by King et al., 18 X-rays may be normal or reveal soft tissue edema, signs compatible with osteoarthritis (new bone formation and/or reduction of intervertebral space), clearly-defi ned subchondral bone cysts, erosions with sclerotic borders, erosion of the odontoid process, atlanto-axial subluxation and pathologic fracture. 18, 19 Among the fi ndings listed above, the most common were those suggestive of osteoarthritis, seen in 26 (65%) of the 40 reports in which a spinal radiography was described. Fig. 1 shows a thoracic radiography of a patient followed at our clinic due to longstanding gout and thoracic (T7) spinal involvement.
Although not frequently mentioned in the literature, computed tomography may show erosions located in facet joints 20 and damage to soft tissue with the presence of low-density nodule or mass in some cases. 21 In magnetic resonance imaging (MRI), tophaceous gout is usually characterized by a homogeneous image with a signal ranging from intermediate to low on T1 (with the same signal intensity as muscle), and on T2, the image appears homogeneous and may show low or high intensity. [22] [23] [24] [25] When contrast (gadolinium) is used, peripheral heterogeneous or homogeneous contrast enhancement may occur, revealing reactive vascularization. 22, 26 Fig . 2 shows the MRI of the lumbar spine of the same patient described above.
The tophus does not present a characteristic image and so it is diffi cult to differentiate it from other types of lesion, such as neoplasms, infections and abscesses. As a result, the fi nal diagnosis often requires histopathological or cytological analyses. The most common fi ndings in imaging study are listed in Table 3 .
Diagnosis
In 103 of the 113 cases (91.2%), a diagnosis was achieved through cytological or histopathological studies. A histological study of the tissue removed during the surgical excision of the lesion or decompressive laminectomy was performed in 87 patients (77%). Guided puncture was done in 16 patients (14.2%), biopsy being unnecessary; and an open biopsy was performed in one (0.9%). 27 A pasty, chalky-white mass was usually observed during the surgery.
In seven patients (6.2%), 8, 17, 23, 24, [28] [29] [30] histological or cytological tests were not performed, and diagnosis was presumed based on clinical and imaging fi ndings or on arthrocentesis of other joints. In another four cases (3.5%) diagnosis was made during autopsy, 1,2,13,14 but none of them died because of spinal involvement by gout.
In 17 patients who reported pain without neurological manifestation, guided puncture or surgical intervention was performed based on the presence of abnormalities in CT and/ or MRI (mass lesion), and eventually fever and elevation in ESR at onset.
The histological description includes classic gout aspects, such as the presence of histiocytes and multinucleated giant cells and fi broblasts surrounding eosinophilic debris or amorphous material, and may contain needle-shaped crystals with negative birefringence under polarized light. Occasionally, only the negative image of the crystals is observed in the neutrophils, as they are dissolved during fi xation in aqueous medium.
31-33
Treatment
Among the 88 patients with neurological symptoms, 74 (84.1%) underwent surgery. The most common procedure was decompressive laminectomy. Full recovery of neurological manifestations was observed in 55 of 74 patients (74.3%); partial recovery followed surgery in nine, and two patients 31, 34 reported no recovery after surgery, although one of them 34 improved after subsequent clinical treatment with non-steroidal antiinfl ammatory (NSAIDs) and hypouricemic drugs. In another six cases there was no follow-up description and thus no data about response to surgery could be retrieved. Only one patient without neurological symptoms was managed surgically but there was no mention to outcomes. Two patients died in the post operatory status due to bronchopneumonia, 15,28 one of them had not shown any improvement, while the other was actually getting better from the neurological symptoms before the infectious complication.
Twenty-fi ve patients (22.1%) received clinical treatment alone (NSAIDs, colchicines and oral, intravenous or epidural corticosteroid) with recovery from neurological defi cits and/ or pain. In three cases managed conservatively the outcome was not reported. 6, 23, 35 Three patients who did not undergo surgery died from bronchopneumonia, 1,9,17 one of them had been improving from the symptoms related to gout, whilst the other two had not. In eight cases there was no mention to management and outcome. Treatment outcomes are summarized in Fig. 2 .
Discussion
Spinal involvement in gout arthritis is increasingly recognized as an unusual manifestation; however its prevalence is clearly underestimated because only those patients with neurological defi cits and/or fever, and those who do not improve with clinical treatment are investigated with imaging and subsequent histopathological studies to confi rm the diagnosis.
Although considered to be a rare manifestation of gout, mainly because most of the cases reported are of symptomatic clinical scenarios (98.2% of the 113 patients reviewed in this article), some evidence point out to the fact that spinal No response (n = 2)
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Unknown outocome (n = 7)
Unknown outcome (n = 3)
Death due to bronchopneumonia (n = 2) Improvement (n = 25) alterations in gout might be much more common than previously thought. Konatalapalli et al. 36 retrospectively reviewed 64 CT images of the spine from patients with gout, and found out that 14% of them presented features of spinal gout. The same research group performed a prospective study in which 48 subjects with a diagnosis of gout had a spinal CT scan. 37 Thirty-fi ve percent of the patients had CT scan evidence of spinal gout erosions or tophi. Since these two studies were not case reports and therefore did not mention any individual clinical info on each patient, they were not included in our analysis.
Axial gout should be considered in the differential diagnosis of patients with previous diagnosis of gout or a history of hyperuricemia who present symptoms suggesting spinal cord involvement and lumbar or cervical pain. Although usually not mentioned in many case reports, risk factors for the development of acute gout such a as renal failure, drugs (diuretics, low-dose aspirin), diet, alcohol intake, and infection should also be considered for the presumptive diagnosis of spinal gout.
The mechanism associated with axial gout is not yet clear. However, it is assumed that the same factors leading to the peripheral picture such as pH, temperature, trauma and joint degeneration are involved in crystal deposits. 33, 38 Finally, the presence of spinal osteoarthritis perhaps also facilitates further crystal deposition.
In patients with no history of gout or hyperuricemia, the diagnosis may be presumed from CT scan, MRI study, clinical and laboratorial fi ndings, previous medical history, and associated risk factors. Plain radiography is a relatively limited diagnostic resource.
Histological or cytological analysis is necessary for a definite diagnosis and to exclude infectious processes or neoplasms which may have similar clinical and imaging aspects, especially in patients without history of gout and/or those with signs and symptoms of red fl ags for back pain. The sample should be preserved in alcohol to prevent urate crystals dissolution. 33 Patients without neurological involvement may initially be treated with NSAIDs, as indicated in acute gout attacks, 39, 40 and subsequently with hypouricemic drugs. In the presence of neurological symptoms, clinical treatment may also be tried, as it leads to improvement in some patients. The favorable response to clinical treatment alone may suggest that the infl ammatory process, rather than a compression due to tophi itself, should be the main mechanism for the development of symptoms.
In a previous review of spinal gout made by Hou et al., 22 after an initial clinical, laboratorial and imaging evaluation, biopsy is suggested as defi nite diagnosis procedure. If there are progressive neurologic defi cits, surgery may be preferred. If biopsy confi rms the diagnosis of gout, conservative treatment may be tried, and when symptoms persist or recur after initial improvement, surgery must be performed. We recommend guided puncture rather than open biopsy in those patients without severe or progressive neurological involvement, and in those with pain as sole manifestation that did not improve with clinical treatment.
In conclusion, gout should be included in the differential diagnosis of acute spinal pain episodes, associated or not with neurological manifestations in patients with a history of gout and hyperuricemia. In the cases without or with mild to moderate neurological manifestations, we recommend guided puncture as initial diagnostic procedure, and conservative treatment with NSAIDs and/or corticosteroids. Surgery must be reserved for those patients with no improvement or those with progressive neurologic defi cits, despite clinical treatment.
